Reviva Pharmaceuticals Holdings, Inc.
- RVPH
- OTC
- Biotechnology
- CNS/Psychiatry Drug Development
- Respiratory/Inflammatory Disease
$0.50
Today +5.26%Quote Oct 16, 2026, 07:48 PM UTC
−0.42%over the last month
Max drawdown −11.0%From 1-month high −5.3%3 months −7.4%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$6.6M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$0.47
6.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RVPHPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
14
Founded
2018